• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100139
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
Investigation conclusion: lot 050726c was manufactured prior to 2007.A review of the available historical documents did not uncover any information that the lot was notable in its performance.Due to the age of the product, no additional investigation can be performed.Alere has withdrawn the alere inratio®/inratio®2 pt/inr system from the market and is no longer manufacturing alere inratio® test strips and monitors.In addition, all alere inratio® test strips are now expired.Further investigation is not possible at this time.Based on the information available, there is no indication of a product deficiency and no corrective action is required.
 
Event Description
The son of the patient initially called in response to the inratio withdrawal notification.The patient was reported as using the inratio system between 2007 and 2009.During this time, the patient experienced correlation and precision issues on three inratio monitors for two lots of inratio test strips (refer to mdr 2027969-2018-00085 for alternate lot number).The patient's therapeutic range was 2.0-3.0.The patient's inratio inr results varied by 20% (both high and low) as compared to the laboratory.Additionally, the patient would test multiple times in a row on the same monitor and across the other monitors and the inratio inr results would vary.The patient's prescribed warfarin dosage may have been adjusted based on the inratio inr results but the son cannot recall the dosage changes or whether the laboratory inr results influenced these changes.The son of the patient confirmed that no adverse outcomes occurred.The patient discontinued use of the inratio system in 2009.The son of the patient stated that he performed troubleshooting by testing a female non-coumadin user.The son expected to receive an inr of 1.0 but "the results were also all over the place" while using the same three inratio monitors and two lot numbers.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key7660406
MDR Text Key113457572
Report Number2027969-2018-00086
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Patient Family Member or Friend
Remedial Action Recall
Type of Report Initial
Report Date 07/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100139
Device Lot Number050726C
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Removal/Correction NumberZ-2354, 2362-2016
Patient Sequence Number1
-
-